In the week of October 20, 2025, 21 holders filed a new Schedule 13D and 58 a new Schedule 13G reporting 5% or more of a company, and 1 13D filing stated an intent to influence the company. The largest stake reported that week is Lucent Strategic Materials Mexico, S. de R.L. de C.V.'s 73.7% of Lucent, Inc. (Schedule 13G, October 22, 2025).
The week of 2025-10-20, 21 holders filed a new Schedule 13D and 58 a new Schedule 13G reporting 5% or more of a company, and 1 13D filing stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2025-10-22 | Megan Holdings Ltd. | Hoo Wei Sern | 66.7% | SCHEDULE 13D |
| 2025-10-24 | Hang Feng Technology Innovation Co., Ltd. | Fenglei Qian | 58.21% | SCHEDULE 13D |
| 2025-10-23 | Neuphoria Therapeutics Inc. | Lynx1 Capital Management LP | 37.1% | SCHEDULE 13D |
| 2025-10-21 | Endovia Health Sciences, Inc. | Devereux William T | 29.4% | SCHEDULE 13D |
| 2025-10-21 | Endovia Health Sciences, Inc. | Yorke Justin W | 28.6% | SCHEDULE 13D |
| 2025-10-24 | Agroz Inc. | Gerard Kim Meng Lim | 28.47% | SCHEDULE 13D |
| 2025-10-21 | Endovia Health Sciences, Inc. | Caple Frederick William | 24.1% | SCHEDULE 13D |
| 2025-10-21 | Endovia Health Sciences, Inc. | Meissner William R. | 23.8% | SCHEDULE 13D |
| 2025-10-20 | Airwa Inc. | Belfiore Michael Anthony | 22.1% | SCHEDULE 13D |
| 2025-10-23 | Origin Agritech Limited | Ausgood Lifestyle Company Limited | 15.31% | SCHEDULE 13D |
| 2025-10-22 | Nabors Energy Transition Corp. II | Funicular Funds, LP | 13.7% | SCHEDULE 13D |
| 2025-10-23 | CIMG Inc. | Dixon Perez Dai | 13.1% | SCHEDULE 13D |
| 2025-10-21 | Seneca Bancorp, Inc. | Zames Mark | 9.2% | SCHEDULE 13D |
| 2025-10-24 | Gold Royalty Corp. | Tether Holdings, S.A. de C.V. | 8.1% | SCHEDULE 13D |
| 2025-10-20 | Eaton Vance Short Duration Diversified Income Fund | Sit Investment Associates, Inc. | 6.4% | SCHEDULE 13D |
| 2025-10-24 | Agroz Inc. | Kay Yen Tan | 5.98% | SCHEDULE 13D |
| 2025-10-21 | Inventiva S.A. | Samsara BioCapital, L.P. | 5.9% | SCHEDULE 13D |
| 2025-10-24 | Astria Therapeutics, Inc. | Magnetar Financial LLC | 5.87% | SCHEDULE 13D |
| 2025-10-20 | Eaton Vance Ltd Duration Income Fund | Sit Investment Associates, Inc. | 5.6% | SCHEDULE 13D |
| 2025-10-24 | Metalla Royalty & Streaming Ltd. | Tether Holdings, S.A. de C.V. | 5.5% | SCHEDULE 13D |
| 2025-10-24 | Maxcyte, Inc. | River Global Investors Llp | 5.2% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2025-10-22 | Lucent, Inc. | Lucent Strategic Materials Mexico, S. de R.L. de C.V. | 73.7% | SCHEDULE 13G |
| 2025-10-24 | CNL Strategic Residential Credit, Inc. | Balbec Capital Holdings, L.P. | 50% | SCHEDULE 13G |
| 2025-10-24 | CNL Strategic Residential Credit, Inc. | CNL Residential Credit Manager, LLC | 50% | SCHEDULE 13G |
| 2025-10-22 | iPower Inc. | Allan James Huang | 24.6% | SCHEDULE 13G |
| 2025-10-24 | Nexentis Technologies Inc. | SciSparc Ltd. | 18.3% | SCHEDULE 13G |
| 2025-10-24 | CIMG Inc. | Sanwei Liu | 14.71% | SCHEDULE 13G |
| 2025-10-20 | RedHill Biopharma Ltd. | Alumni Capital LP | 9.99% | SCHEDULE 13G |
| 2025-10-21 | X4 Pharmaceuticals Inc | Empery Asset Management, LP | 9.99% | SCHEDULE 13G |
| 2025-10-21 | American Resources Corp | Kenneth Griffin | 9.99% | SCHEDULE 13G |
| 2025-10-23 | Rani Therapeutics Holdings, Inc. | Raymond Debbane | 9.99% | SCHEDULE 13G |
| 2025-10-20 | C4 Therapeutics, Inc. | Point72 Asset Management, L.P. | 9.9% | SCHEDULE 13G |
| 2025-10-20 | Perpetuals.com Ltd | Strategic EP, LLC | 9.9% | SCHEDULE 13G |
| 2025-10-24 | Electra Battery Materials Corp | Highbridge Capital Management LLC | 9.9% | SCHEDULE 13G |
| 2025-10-24 | Electra Battery Materials Corp | Whitebox Advisors LLC | 9.9% | SCHEDULE 13G |
| 2025-10-24 | Electra Battery Materials Corp | OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 9.9% | SCHEDULE 13G |
| 2025-10-24 | C4 Therapeutics, Inc. | RA Capital Management, L.P. | 9.9% | SCHEDULE 13G |
| 2025-10-23 | FG Nexus Inc. | Syncracy Operational Management LLC | 9.8% | SCHEDULE 13G |
| 2025-10-24 | Sky Quarry Inc. | Jpmorgan Chase & Co | 9.6% | SCHEDULE 13G |
| 2025-10-21 | Immuneering Corp | Empery Asset Management, LP | 8.83% | SCHEDULE 13G |
| 2025-10-24 | Eagle Bancorp Inc | North Reef Capital Management LP | 8.7% | SCHEDULE 13G |
| 2025-10-22 | Keros Therapeutics, Inc. | Tang Capital Management, LLC | 7.9% | SCHEDULE 13G |
| 2025-10-23 | Sutro Biopharma, Inc. | Affinity Healthcare Fund, LP | 7.77% | SCHEDULE 13G |
| 2025-10-21 | Tsakos Energy Navigation Ltd | Castleknight Master Fund LP | 7.5% | SCHEDULE 13G |
| 2025-10-21 | Jiuzi Holdings, Inc. | Empery Asset Management, LP | 7.45% | SCHEDULE 13G |
| 2025-10-22 | Invivyd, Inc. | Bvf Partners L P | 7.4% | SCHEDULE 13G |
| 2025-10-20 | Perpetuals.com Ltd | Eadwacer Holdings, LLC | 7.3% | SCHEDULE 13G |
| 2025-10-24 | Warby Parker Inc. | Jpmorgan Chase & Co. | 6.9% | SCHEDULE 13G |
| 2025-10-20 | 4d Molecular Therapeutics, Inc. | Novo Holdings A/S | 6.8% | SCHEDULE 13G |
| 2025-10-24 | NextCure, Inc. | Squadron Capital Management LLC | 6.5% | SCHEDULE 13G |
| 2025-10-22 | Neogen Corp | Ing Groep Nv | 6.47% | SCHEDULE 13G |
| 2025-10-24 | C4 Therapeutics, Inc. | BCLS II Equity Opportunities, LP | 6.25% | SCHEDULE 13G |
| 2025-10-22 | FTAI Aviation Ltd. | Shikiar Asset Management Inc | 6.1% | SCHEDULE 13G |
| 2025-10-23 | City Office Reit, Inc. | Glazer Capital, LLC | 5.98% | SCHEDULE 13G |
| 2025-10-22 | Quantum X Labs Inc. | Nissim Daniel | 5.72% | SCHEDULE 13G |
| 2025-10-22 | Hyperion DeFi | Forsakringsaktiebolaget Avanza Pension | 5.62% | SCHEDULE 13G |
| 2025-10-22 | Flaherty & Crumrine Dynamic Preferred & Income Fund Inc | Raymond James & Associates | 5.6% | SCHEDULE 13G |
| 2025-10-23 | Keel Infrastructure Corp. | Jane Street Group, LLC | 5.4% | SCHEDULE 13G |
| 2025-10-24 | Upstream Bio Inc | Norges Bank | 5.3% | SCHEDULE 13G |
| 2025-10-20 | ATS Corp | Royal Bank of Canada | 5.26% | SCHEDULE 13G |
| 2025-10-20 | Beyond Meat, Inc. | Context Capital Management, LLC | 5.2% | SCHEDULE 13G |
| 2025-10-21 | New York Times Co-A | Darsana Capital Partners LP | 5.2% | SCHEDULE 13G |
| 2025-10-21 | Invesco Ltd. | Millennium Management LLC | 5.2% | SCHEDULE 13G |
| 2025-10-22 | Spring Valley Acquisition Corp. II | Merus Global Investments, LLC | 5.2% | SCHEDULE 13G |
| 2025-10-22 | Centrus Energy Corp | D. E. Shaw & Co., L.P. | 5.2% | SCHEDULE 13G |
| 2025-10-23 | Cardiol Therapeutics Inc. | Tejara Capital Ltd | 5.2% | SCHEDULE 13G |
| 2025-10-24 | Immunocore Holdings plc | Tang Capital Management, LLC | 5.2% | SCHEDULE 13G |
| 2025-10-23 | Cayson Acquisition Corp | Feis Equities LLC | 5.18% | SCHEDULE 13G |
| 2025-10-21 | Nano Nuclear Energy Inc | Kenneth Griffin | 5.1% | SCHEDULE 13G |
| 2025-10-23 | Sprott Physical Platinum & Palladium Trust | Raymond James & Associates | 5.1% | SCHEDULE 13G |
| 2025-10-23 | Verastem Inc | Foresite Capital Fund VI LP | 5.1% | SCHEDULE 13G |
| 2025-10-24 | Arrow Electronics, Inc. | ACR Alpine Capital Research, LLC | 5.1% | SCHEDULE 13G |
| 2025-10-21 | Better Home & Finance Holding Company | Orange Capital Ventures, LP | 5.03% | SCHEDULE 13G |
| 2025-10-23 | First Horizon Corp | Millennium Management LLC | 5% | SCHEDULE 13G |
| 2025-10-23 | Cipher Digital Inc. | Jane Street Group, LLC | 5% | SCHEDULE 13G |
| 2025-10-23 | Hut 8 Corp. | Jane Street Group, LLC | 5% | SCHEDULE 13G |
| 2025-10-24 | Willscot Holdings Corporation | Jpmorgan Chase & Co. | 5% | SCHEDULE 13G |
| 2025-10-24 | Etsy Inc | Lone Pine Capital LLC | 5% | SCHEDULE 13G |
| 2025-10-24 | Wynn Resorts Ltd | Blossom Fountain Limited | 5% | SCHEDULE 13G |
Stated intent
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2025-10-20 | CollPlant Biotechnologies Ltd. | Loewenbaum Lilian S. intent stated | 9.9% | SCHEDULE 13D/A |
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.